News

Hosted on MSN15d
How glycoprotein GP38 from Crimean-Congo hemorrhagic fever virus could advance monoclonal antibody therapies
There are currently no approved vaccines against the virus. Historically, GP38 has been considered an important target for vaccines or other treatments. However, the lack of knowledge regarding ...
News Medical15d
GP38 identified as key viral toxin and vaccine target in Crimean-Congo hemorrhagic fever virus research
There are currently no approved vaccines against the virus. Historically GP38 has been considered an important target for vaccines or other treatments. However, the lack of knowledge regarding ...